Back to News
Market Impact: 0.25
Wednesday's ETF Movers: PPH, SILJ
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
On Wednesday, the VanEck Pharmaceutical ETF was up about 2.9%, outperforming other ETFs. AstraZeneca shares gained about 4.4% and Merck shares rose about 4.2%; the article provides no reason for the gains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
AZN0.30
MRK0.30
More News
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
- SK Hynix plunges 8% amid Asia tech rout as Fed rate hike fears, AI funding worries mount
- Why is Samsung Electronics stock plunging today?
- Why is Advantest stock plummeting today?
- Japan, U.S. reach first chip deal under $550 bln investment plan
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory